In a report released today, Nick Setyan from Wedbush maintained a Hold rating on Lennar (LEN – Research Report), with a price target of ...
Wedbush analyst Nick Setyan reiterated a Buy rating on Darden Restaurants (DRI – Research Report) today and set a price target of $235.00. The ...
Long-time Tesla bull Dan Ives, an analyst at Wedbush Securities, says Elon Musk is the only one who can turn the EV maker's ...
Wedbush Securities backed its Outperform rating on Tesla (NASDAQ:TSLA) and $550 price target on Thursday, although the firm ...
Analysts at Wedbush dropped their Q1 2025 earnings estimates for Getty Images in a report released on Tuesday, March 18th.
Fintel reports that on March 20, 2025, Wedbush initiated coverage of Zenas BioPharma (NasdaqGS:ZBIO) with a Outperform ...
Ubisoft is banking on the success of "Assassin's Creed Shadows" to fight its way out of financial troubles as the French ...
Zenas BioPharma (ZBIO) stock rises as Wedbush issues a bullish recommendation based on the company's lead asset obexelimab. Read more here.
Delays in AI improvements and the next-generation Siriwhich are currently anticipated with iPhone 17have put pressure on Apple shares, claims Wedbush analyst Daniel Ives. A sluggish tech ...
Google announced a deal Tuesday to buy rapidly growing cybersecurity firm Wiz for $32 billion. It will be the tech giant’s ...
Vigil Neuroscience, Inc. (NASDAQ:VIGL – Free Report) – Equities researchers at Wedbush issued their FY2029 ... Finally, JMP Securities reaffirmed a “market outperform” rating and issued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results